VVOS - Vivos Therapeutics Lincare ink distribution deal
2023-10-24 09:17:29 ET
- Medical technology firm Vivos Therapeutics ( NASDAQ: VVOS ) has entered into a U.S. nationwide distribution deal with in-home respiratory therapy products supplier, Lincare.
- Under the deal, Lincare will have a six-month exclusivity to distribute certain designated Vivos devices. The agreement follows the successful conclusion of a distribution pilot with Lincare.
- Kirk Huntsman, Chairman and CEO of Vivos, stated, "Across the United States, hundreds of thousands of new CPAP units are rented or sold through DME companies each month. Lincare is one of the market leaders in this sector, and we are pleased to join forces with them in this pioneering initiative."
- Shares of Vivos Therapeutics ( VVOS ) have gained 12% premarket
For further details see:
Vivos Therapeutics, Lincare ink distribution deal